Altimmune (ALT) Exchange Rate Effect (2010 - 2018)
Altimmune (ALT) posted quarterly Exchange Rate Effect of -$48470.0 for Q2 2018, down 209.77% year-over-year from $44154.0 in Q2 2017, and down 2457.78% quarter-over-quarter from -$1895.0 in Q1 2018.
Altimmune (ALT) Exchange Rate Effect (2010 - 2018) Analysis & Trends
Altimmune (ALT) has reported Exchange Rate Effect for 9 consecutive years, with -$48470.0 the latest figure, recorded in Q2 2018.
- In Q2 2018, Exchange Rate Effect fell 209.77% year-over-year to -$48470.0; the TTM figure through Dec 2018 stood at -$50365.0 (down 167.71% YoY), while the FY2018 annual figure was -$50365.0, down 167.71% from the prior year.
- Exchange Rate Effect declined to -$48470.0 in Q2 2018 per ALT's latest filing, from -$1895.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $44154.0 in Q2 2017 and bottomed at -$98830.0 in Q2 2016.
- Historically, Exchange Rate Effect has averaged -$9007.7 across 5 years, with a median of -$1696.0 in 2016.
- Annual changes were most pronounced in 2015 — Exchange Rate Effect jumped 2436.12% — and 2016, when it sank 13782.14%.
- Altimmune's Exchange Rate Effect stood at -$5256.0 in 2014, then soared by 63.01% to -$1944.0 in 2015, then climbed by 22.99% to -$1497.0 in 2016, then tumbled by 734.47% to -$12492.0 in 2017, then sank by 288.01% to -$48470.0 in 2018.
- Business Quant data shows ALT's Exchange Rate Effect at -$48470.0 in Q2 2018, -$1895.0 in Q1 2018, and -$12492.0 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -48,470.00 |
| Jun 30, 2018 | -48,470.00 |
| Mar 31, 2018 | -1,895.00 |
| Mar 31, 2018 | -1,895.00 |
| Dec 31, 2017 | -12,492.00 |
| Dec 31, 2017 | -12,492.00 |
| Sep 30, 2017 | 35,326.00 |
| Sep 30, 2017 | 35,326.00 |
| Jun 30, 2017 | 44,154.00 |
| Jun 30, 2017 | 44,154.00 |
| Mar 31, 2017 | 7,399.00 |
| Mar 31, 2017 | 7,399.00 |
| Dec 31, 2016 | -1,497.00 |
| Dec 31, 2016 | -1,497.00 |
| Sep 30, 2016 | -69,966.00 |
| Sep 30, 2016 | -69,966.00 |
| Jun 30, 2016 | -98,830.00 |
| Jun 30, 2016 | -98,830.00 |
| Mar 31, 2016 | -1,252.00 |
| Mar 31, 2016 | -1,252.00 |